Andamertinib
N-[4-methoxy-2-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]-5-[[6-(1-methylindazol-5-yl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide
Molecular Identity
Andamertinib
N-[4-methoxy-2-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]-5-[[6-(1-methylindazol-5-yl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide
PubChem CID: 146498390
2D Structure
Properties
C31H36N8O3
Molecular Formula
568.70
Molecular Weight
g/mol
568.2910
Exact Mass
Da
3.5
XLogP
Drug-like (Lipinski: < 5)
110
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
9
H-Bond Acceptors
913
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(14)
Andamertinib2254145-43-0andamertinib [INN]5X3KAG7ZBWorb3028552SCHEMBL21871533GTPL13732PLB1004PLB-1004compound 206 [WO2018228446A1]2-Propenamide, N-[4-methoxy-2-[4-(3-methoxy-1-azetidinyl)-1-piperidinyl]-5-[[6-(1-methyl-1H-indazol-5-yl)-4-pyrimidinyl]amino]phenyl]-N-(4-methoxy-2-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]-5-{[6-(1-methyl-1H-indazol-5-yl)pyrimidin-4-yl]amino}phenyl)prop-2-enamideN-[4-Methoxy-2-[4-(3-methoxy-1-azetidinyl)-1-piperidinyl]-5-[[6-(1-methyl-1H-indazol-5-yl)-4-pyrimidinyl]amino]phenyl]-2-propenamideN-[4-methoxy-2-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]-5-[[6-(1-methylindazol-5-yl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Andamertinib
Loading drug network...